litlas
ログインアカウント作成

Joachim Listing

1985–2024 年に発表

84
論文数
24,386
被引用数
77
h 指数
84
i10 指数

被引用数

Joachim Listing の年別被引用数1986 年: 被引用 2 件1987 年: 被引用 3 件1988 年: 被引用 1 件1989 年: 被引用 2 件1990 年: 被引用 3 件1991 年: 被引用 1 件1992 年: 被引用 1 件1993 年: 被引用 2 件1995 年: 被引用 1 件1996 年: 被引用 1 件1997 年: 被引用 9 件1998 年: 被引用 4 件1999 年: 被引用 6 件2000 年: 被引用 3 件2001 年: 被引用 5 件2002 年: 被引用 24 件2003 年: 被引用 47 件2004 年: 被引用 67 件2005 年: 被引用 146 件2006 年: 被引用 120 件2007 年: 被引用 148 件2008 年: 被引用 145 件2009 年: 被引用 171 件2010 年: 被引用 188 件2011 年: 被引用 319 件2012 年: 被引用 220 件2013 年: 被引用 260 件2014 年: 被引用 237 件2015 年: 被引用 248 件2016 年: 被引用 178 件2017 年: 被引用 216 件2018 年: 被引用 166 件2019 年: 被引用 695 件2020 年: 被引用 691 件2021 年: 被引用 521 件2022 年: 被引用 364 件2023 年: 被引用 263 件2024 年: 被引用 412 件2025 年: 被引用 109 件2026 年: 被引用 6 件1994 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,193 件、この内訳の 15.4%ドイツ: 引用元論文 715 件、この内訳の 9.2%イギリス: 引用元論文 660 件、この内訳の 8.5%オランダ: 引用元論文 509 件、この内訳の 6.5%フランス: 引用元論文 434 件、この内訳の 5.6%カナダ: 引用元論文 388 件、この内訳の 5%イタリア: 引用元論文 379 件、この内訳の 4.9%スペイン: 引用元論文 304 件、この内訳の 3.9%中国: 引用元論文 256 件、この内訳の 3.3%ベルギー: 引用元論文 228 件、この内訳の 2.9%スイス: 引用元論文 228 件、この内訳の 2.9%デンマーク: 引用元論文 191 件、この内訳の 2.5%
0%15.4%その他 29.4%

機関

分野

  • Medicine88.1%
  • Biochemistry, Genetics and Molecular Biology5.2%
  • Immunology and Microbiology4.1%
  • Nursing0.5%
  • Health Professions0.4%
  • Neuroscience0.3%
  • その他1.4%

トピック

  • Rheumatoid Arthritis Research and Therapies19.9%
  • Spondyloarthritis Studies and Treatments18.7%
  • Autoimmune and Inflammatory Disorders Research6.9%
  • Psoriasis: Treatment and Pathogenesis4.6%
  • Spine and Intervertebral Disc Pathology4%
  • Systemic Lupus Erythematosus Research3.4%
  • その他42.5%

共著者

全論文

検索で開く
  1. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection

    著者: Martín Rudwaleit, Désirée van der Heijde, R. B. M. Landewé, Joachim Listing, Nurullah Akkoç, J. Brandt, Jürgen Braun, Chung‐Tei Chou, Eduardo Collantes‐Estévez, Maxime Dougados, Feng Huang, Jieruo Gu, Muhammad Asim Khan, Yeşim Kirazlı, Walter P. Maksymowych, Herman Mielants, Inge Juul Sørensen, S Ozgocmen, Euthalia Roussou, Raphael Valle-Oñate, Ulrich Weber, James Cheng‐Chung Wei, Joachim Sieper - Annals of the Rheumatic Diseases 2009 被引用: 3,622

  2. American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials

    著者: David T. Felson, Josef S Smolen, George A. Wells, Bin Zhang, L. van Tuyl, Julia Funovits, Daniel Aletaha, Cornelia F Allaart, Joan M. Bathon, Stefano Bombardieri, Peter Brooks, Andrew Brown, Marco Matucci‐Cerinic, Hyon K. Choi, Bernard Combe, Maarten de Wit, Maxime Dougados, Paul Emery, Daniel E. Furst, Juan J. Gómez‐Reino, Gillian Hawker, Edward Keystone, Dinesh Khanna, John Kirwan, Tore K Kvien, Robert Landewé, Joachim Listing, Kaleb Michaud, E. Martín‐Mola, Pamela Montie, Theodore Pincus, Pamela Richards, Jeffrey N. Siegel, Lee S. Simon, Tuulikki Sokka, Vibeke Strand, Peter Tugwell, Alan Tyndall, Desirée van der Heijde, Suzanne Verstappen, Barbara White, Frederick Wolfe, A. Zink, Maarten Boers - Annals of the Rheumatic Diseases 2011 被引用: 1,019

  3. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal

    著者: Martín Rudwaleit, R. Landewé, Désirée van der Heijde, Joachim Listing, J. Brandt, Joseph M. Braun, R Burgos-Vargas, Eduardo Collantes‐Estévez, John C. Davis, Ben A. C. Dijkmans, Maxime Dougados, Paul Emery, Irene E. van der Horst‐Bruinsma, Robert D. Inman, Muhammad Asim Khan, Marjatta Leirisalo‐Repo, S. van der Linden, Walter P. Maksymowych, Herman Mielants, Ignazio Olivieri, R D Sturrock, Kurt De Vlam, Joachim Sieper - Annals of the Rheumatic Diseases 2009 被引用: 943

  4. ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis

    著者: Désirée van der Heijde, E. Lie, Tore K Kvien, Joachim Sieper, Filip Van den Bosch, Joachim Listing, Joseph M. Braun, R. Landewé - Annals of the Rheumatic Diseases 2008 被引用: 631

  5. Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force

    著者: Cindy Strehl, J. W. J. Bijlsma, Maarten de Wit, Maarten Boers, N. Caeyers, Maurizio Cutolo, Bhaskar Dasgupta, William G Dixon, Rinie Geenen, T. Huizinga, Alison Kent, Annette de Thurah, Joachim Listing, Xavier Mariette, David Ray, Hans Ulrich Scherer, Raphaèle Séror, Cornelia M Spies, Simon Tarp, Dieter Wiek, Kevin Winthrop, Frank Buttgereit - Annals of the Rheumatic Diseases 2016 被引用: 331

  6. The early disease stage in axial spondylarthritis: Results from the german spondyloarthritis inception cohort

    著者: Martín Rudwaleit, Hildrun Haibel, Xenofon Baraliakos, Joachim Listing, E. Märker‐Hermann, H. Zeidler, Jürgen Braun, Joachim Sieper - Arthritis & Rheumatism 2009 被引用: 725

  7. The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment

    著者: Joachim Listing, Kerstin Gerhold, A. Zink - Lara D. Veeken 2012 被引用: 542

  8. Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximab

    著者: Joachim Listing, Jörn Kekow, Bernhard Manger, Gerd‐Rüdiger Burmester, Dagmar Pattloch, A. Zink, Anja Strangfeld - Annals of the Rheumatic Diseases 2013 被引用: 288

  9. Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

    著者: Jürgen Braun, J. Brandt, Joachim Listing, A. Zink, Rieke Alten, W. Golder, E Gromnica-lhle, H. Kellner, Andreas Krause, Matthias Schneider, H. Sörensen, H. Zeidler, Wolfgang Thriene, Joachim Sieper - The Lancet 2002 被引用: 1,266

  10. Baseline radiographic damage, elevated acute‐phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis

    著者: Denis Poddubnyy, Hildrun Haibel, Joachim Listing, E. Märker‐Hermann, H. Zeidler, Jürgen Braun, Joachim Sieper, Martín Rudwaleit - Arthritis & Rheumatism 2011 被引用: 468

  11. Canakinumab for Treatment of Adult-Onset Still's Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial

    著者: Claudia Kedor, Joachim Listing, Jan Zernicke, Anja Weiß, Frank Behrens, Norbert Blank, Jörg Henes, Joern Kekow, Andrea Rubbert‐Roth, Hendrik Schulze‐Koops, Eva Seipelt, Christof Specker, Eugen Feist - Annals of the Rheumatic Diseases 2020 被引用: 99

  12. Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?

    著者: Anja Strangfeld, Maria Eveslage, Matthias Schneider, H. J. Bergerhausen, T. Klopsch, A. Zink, Joachim Listing - Annals of the Rheumatic Diseases 2011 被引用: 362

  13. Effect of continuous versus on-demand treatment of ankylosing spondylitis with diclofenac over 2 years on radiographic progression of the spine: results from a randomised multicentre trial (ENRADAS)

    著者: Joachim Sieper, Joachim Listing, Denis Poddubnyy, In‐Ho Song, Kay‐Geert Hermann, Johanna Callhoff, Uta Syrbe, Jürgen Braun, Martín Rudwaleit - Annals of the Rheumatic Diseases 2015 被引用: 227

  14. Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT

    著者: Anja Strangfeld, Franka Hierse, Rolf Rau, Gerd‐Ruediger Burmester, Brigitte Krummel-Lorenz, W. Demary, Joachim Listing, A. Zink - Arthritis Research & Therapy 2010 被引用: 262

  15. Risk for lower intestinal perforations in patients with rheumatoid arthritis treated with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARDs

    著者: Anja Strangfeld, Adrian Richter, Britta Siegmund, P. Herzer, Karin Rockwitz, W. Demary, Martin Aringer, Yvette Meißner, A. Zink, Joachim Listing - Annals of the Rheumatic Diseases 2016 被引用: 193

  16. Inflammatory back pain in ankylosing spondylitis: A reassessment of the clinical history for application as classification and diagnostic criteria

    著者: Martín Rudwaleit, Anke Metter, Joachim Listing, Joachim Sieper, Jürgen Braun - Arthritis & Rheumatism 2006 被引用: 545

  17. Infections in patients with rheumatoid arthritis treated with biologic agents

    著者: Joachim Listing, Anja Strangfeld, S. Kary, Rolf Rau, U von Hinueber, Maria Stoyanova‐Scholz, Erika Gromnica‐Ihle, Christian Antoni, P. Herzer, Jörn Kekow, Matthias Schneider, A. Zink - Arthritis & Rheumatism 2005 被引用: 687

  18. Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis

    著者: Denis Poddubnyy, M. Rudwaleit, Hildrun Haibel, Joachim Listing, Elisabeth Märker‐Hermann, H. Zeidler, J. Braun, J. Sieper - Annals of the Rheumatic Diseases 2011 被引用: 352

  19. Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers

    著者: Louise Mercer, Johan Askling, Pauline Raaschou, William G Dixon, Lene Dreyer, Merete Lund Hetland, Anja Strangfeld, A. Zink, Xavier Mariette, Axel Finckh, Helena Canhão, Florenzo Iannone, Jakub Závada, Jacques Morel, Jacques‐Eric Gottenberg, Kimme L Hyrich, Joachim Listing - Annals of the Rheumatic Diseases 2016 被引用: 188

  20. Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti–tumor necrosis factor agents infliximab and etanercept

    著者: Jürgen Braun, Xenofon Baraliakos, Joachim Listing, Joachim Sieper - Arthritis & Rheumatism 2005 被引用: 442

  21. Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytes

    著者: Xenofon Baraliakos, Joachim Listing, Martín Rudwaleit, Hildrun Haibel, J. Brandt, Joachim Sieper, Jürgen Braun - Annals of the Rheumatic Diseases 2007 被引用: 268

  22. Efficacy of TNFα blockers in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis

    著者: Johanna Callhoff, Joachim Sieper, Anja Weiß, A. Zink, Joachim Listing - Annals of the Rheumatic Diseases 2014 被引用: 213

  23. Which spinal lesions are associated with new bone formation in patients with ankylosing spondylitis treated with anti-TNF agents? A long-term observational study using MRI and conventional radiography

    著者: Xenofon Baraliakos, F. Heldmann, Johanna Callhoff, Joachim Listing, Thierry Appelboom, J. Brandt, Filip Van den Bosch, Maxime Bréban, GR Burmester, Maxime Dougados, Paul Emery, Hill Gaston, Mathias Grünke, Irene E. van der Horst‐Bruinsma, Robert Landewé, Marjatta Leirisalo‐Repo, Joachim Sieper, Kurt de Vlam, Dimitrios A. Pappas, Uta Kiltz, Désirée van der Heijde, Jürgen Braun - Annals of the Rheumatic Diseases 2013 被引用: 195

  24. Does tumor necrosis factor α inhibition promote or prevent heart failure in patients with rheumatoid arthritis?

    著者: Joachim Listing, Anja Strangfeld, Jörn Kekow, Matthias Schneider, A Kapelle, Siegfried Wassenberg, A. Zink - Arthritis & Rheumatism 2008 被引用: 195